Discover
INDV
Indivior Pharmaceuticals Inc
39.13
2 x 39.12
1 x 39.13
bid
ask
+
0.66
1.73%
01:32 PM
timesize
| Ytd | 9.07% | |
| 1y | 75.57% |
38.41
day range
39.15
22.22
52 week range
42.81
| Open | 38.59 | Prev Close | 38.47 | Low | 38.41 | High | 39.15 | Mkt Cap | 4.88B |
| Vol | 1.03M | Avg Vol | 1.96M | EPS | 3.65 | P/E | 10.72 | Forward P/E | 8.43 |
| Beta | 0.86 | Short Ratio | 5.96 | Inst. Own | 114.59% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 06-16 | Earning | 04-30 | 50-d Avg | 39.21 | 200-d Avg | 34.88 | 1yr Est | 49.00 |
| Income Statement | |||
| Total Revenue | 343.00M | ||
| Revenues (USD) | 343.00M | ||
| Cost of Revenue | 50.00M | ||
| Gross Profit | 293.00M | ||
| Operating Expenses | 134.00M | ||
| Research and Development Expense | 12.00M | ||
| Selling, General and Administrative Expense | 122.00M | ||
| Operating Income | 159.00M | ||
| Interest Expense | 2.00M | ||
| Income Tax Expense | 38.00M | ||
| Net Income | 122.00M | ||
| Net Income Common Stock | 122.00M | ||
| Net Income Common Stock (USD) | 122.00M | ||
| Consolidated Income | 122.00M | ||
| Earnings per Basic Share | 1.02 | ||
| Earnings per Basic Share (USD) | 1.02 | ||
| Earnings per Diluted Share | 0.98 | ||
| Earning Before Interest & Taxes (EBIT) | 162.00M | ||
| Earning Before Interest & Taxes (USD) | 162.00M | ||
| Weighted Average Shares | 119.00M | ||
| Weighted Average Shares Diluted | 124.00M | ||
| Balance Sheet | |||
| Cash and Equivalents | 222.00M | ||
| Cash and Equivalents (USD) | 222.00M | ||
| Investments | 27.00M | ||
| Investments Non-Current | 27.00M | ||
| Trade and Non-Trade Receivables | 271.00M | ||
| Current Assets | 725.00M | ||
| Property, Plant & Equipment Net | 183.00M | ||
| Total Assets | 1.23B | ||
| Debt Current | 9.00M | ||
| Total Debt | 509.00M | ||
| Current Liabilities | 868.00M | ||
| Debt Non-Current | 500.00M | ||
| Total Liabilities | 1.44B | ||
| Accumulated Retained Earnings (Deficit) | -334.00M | ||
| Accumulated Other Comprehensive Income | -28.00M | ||
| Shareholders Equity | -208.00M | ||
| Shareholders Equity (USD) | -208.00M | ||
| Assets Non-Current | 508.00M | ||
| Total Debt (USD) | 509.00M | ||
| Goodwill and Intangible Assets | 2.00M | ||
| Inventory | 150.00M | ||
| Liabilities Non-Current | 573.00M | ||
| Trade and Non-Trade Payables | 206.00M | ||
| Tax Assets | 287.00M | ||
| Tax Liabilities | 30.00M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 3.00M | ||
| Net Cash Flow from Financing | -173.00M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 48.00M | ||
| Capital Expenditure | -7.00M | ||
| Issuance (Purchase) of Equity Shares | -176.00M | ||
| Net Cash Flow from Investing | -8.00M | ||
| Net Cash Flow from Operations | 229.00M | ||
| Share Based Compensation | 11.00M | ||